RNA interference targeting mutant p53 inhibits growth and induces apoptosis in DU145 human prostate cancer cells

Medical Oncology

Volumn 28, Issue SUPPL. 1, 2011, Pages

  Zhu, Haibin ^a   Mao, Qiqi ^a   Lin, Yiwei ^a   Yang, Kai ^a   Xie, Liping ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Apoptosis; Cell cycle; Mutant p53; Prostate cancer; RNA interference

Indexed keywords

ANTINEOPLASTIC AGENT; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL VIABILITY; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; M PHASE CELL CYCLE CHECKPOINT; PRIORITY JOURNAL; PROSTATE CANCER; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

EID: 84655175040     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9679-9     Document Type: Article

References (26)

1. A Jemal R Siegel E Ward Y Hao J Xu 2009 Cancer statistics, 2009 CA Cancer J Clin 59 225 249
2. AJ Levine 1997 p53, the cellular gatekeeper for growth and division Cell 88 323 331 (Pubitemid 27131374)
3. M Hollstein D Sidransky B Vogelstein CC Harris 1991 p53 mutations in human cancers Science 253 49 53 (Pubitemid 21917115)
4. J Milner EA Medcalf AC Cook 1991 Tumor suppressor p53: analysis of wild-type and mutant p53 complexes Mol Cell Biol 11 12 19 (Pubitemid 21895176)
5. J Milner EA Medcalf 1991 Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation Cell 65 765 774 (Pubitemid 121001308)
6. T Aas AL Borresen S Geisler B Smith-Sorensen H Johnsen 1996 Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients Nat Med 2 811 814 (Pubitemid 26225099)
7. G Blandino AJ Levine M Oren 1999 Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy Oncog 18 477 485 (Pubitemid 29060623)
8. NM Navone P Troncoso LL Pisters TL Goodrow JL Palmer 1993 p53 protein accumulation and gene mutation in the progression of human prostate carcinoma J Natl Cancer Inst 85 1657 1669
9. LA Perryman JM Blair EA Kingsley B Szymanska KT Ow 2006 Over-expression of p53 mutants in LNCaP cells alters tumor growth and angiogenesis in vivo Biochem Biophys Res Commun 345 1207 1214 (Pubitemid 43776515)
10. M Che M DeSilvio A Pollack DJ Grignon VM Venkatesan 2007 Prognostic value of abnormal p53 expression in locally advanced prostate cancer treated with androgen deprivation and radiotherapy: a study based on RTOG 9202 Int J Radiat Oncol Biol Phys 69 1117 1123 (Pubitemid 47625839)
11. AG Carroll HJ Voeller L Sugars EP Gelmann 1993 p53 oncogene mutations in three human prostate cancer cell lines Prostate 23 123 134 (Pubitemid 23289894)
12. L Xie X Zheng J Qin Z Chen Y Jin 2006 Role of PI3-kinase/Akt signalling pathway in renal function and cell proliferation after renal ischaemia/reperfusion injury in mice Nephrology (Carlton) 11 207 212 (Pubitemid 43829439)
13. LL Ma WJ Sun Z Wang GY Zh P Li 2006 Effects of silencing of mutant p53 gene in human lung adenocarcinoma cell line Anip973 J Exp Clin Cancer Res 25 585 592 (Pubitemid 46166773)
14. A Ivana Scovassi M Diederich 2004 Modulation of poly(ADP-ribosylation) in apoptotic cells Biochem Pharmacol 68 1041 1047 (Pubitemid 39094268)
15. D Sarker AH Reid TA Yap JS de Bono 2009 Targeting the PI3 K/AKT pathway for the treatment of prostate cancer Clin Cancer Res 15 4799 4805
16. EP Slater T Stubig QC Lau TV Achenbach UR Rapp 2003 C-Raf controlled pathways in the protection of tumor cells from apoptosis Int J Cancer 104 425 432 (Pubitemid 36323911)
17. JS Fridman SW Lowe 2003 Control of apoptosis by p53 Oncogene 22 9030 9040 (Pubitemid 38121703)
18. R Li PD Sutphin D Schwartz D Matas N Almog 1998 Mutant p53 protein expression interferes with p53-independent apoptotic pathways Oncogene 16 3269 3277 (Pubitemid 28330425)
19. D Bergamaschi M Gasco L Hiller A Sullivan N Syed 2003 p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis Cancer Cell 3 387 402 (Pubitemid 38340307)
20. D Wolf N Harris V Rotter 1984 Reconstitution of p53 expression in a nonproducer Ab-MuLV-transformed cell line by transfection of a functional p53 gene Cell 38 119 126 (Pubitemid 15216541)
21. PM Ghosh S Malik R Bedolla JI Kreisberg 2003 Akt in prostate cancer: possible role in androgen-independence Curr Drug Metab 4 487 496 (Pubitemid 37536869)
22. R Bookstein D [tmp] MacGrogan SG Hilsenbeck F Sharkey DC Allred 1993 p53 is mutated in a subset of advanced-stage prostate cancers Cancer Res 53 3369 3373 (Pubitemid 23223311)
23. R Brosh V Rotter 2009 When mutants gain new powers: news from the mutant p53 field Nat Rev Cancer 9 701 713
24. P Dong Z Xu N Jia D Li Y Feng 2009 Elevated expression of p53 gain-of-function mutation R175H in endometrial cancer cells can increase the invasive phenotypes by activation of the EGFR/PI3 K/AKT pathway Mol Cancer 8 103
25. F Gesbert WR Sellers S Signoretti M Loda JD Griffin 2000 BCR/ABL regulates expression of the cyclin-dependent kinase inhibitor p27Kip1 through the phosphatidylinositol 3-Kinase/AKT pathway J Biol Chem 275 39223 39230 (Pubitemid 32058940)
26. JA Diehl M Cheng MF Roussel CJ Sherr 1998 Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization Genes Dev 12 3499 3511 (Pubitemid 28553242)